18 May 2015 - Deborah Wilkes
'GSK makes choices in Consumer Healthcare' is a NEWS EXTRA publication that provides rapid insights into GlaxoSmithKline's current strategy for its Consumer Healthcare business. The company says it is now the world's leading OTC player following the formation of a global consumer healthcare joint venture with Novartis on 2 March 2015.
GlaxoSmithKline Consumer Healthcare has a lot more choices worldwide now that the Novartis OTC business is on board.
Chief executive officer Emma Walmsley is taking her pick of these choices, and aims to drive growth from around a dozen key markets, seven power brands and 12 core brands. She also highlights the importance of switching and other forms of innovation, as well as greater penetration in categories and countries, and opportunities in emerging markets.
Other issues at GlaxoSmithKline Consumer Healthcare covered by this 22-page News Extra publication include further acquisitions and divestments, manufacturing problems, and ways of transforming profitability.
The News Extra publication is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.
Around 5,500 words long, the publication is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
The News Extra is available free to people with an Annual Subscription to the OTCToolbox website (click here to find out more).
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box at the top of this page
For alternative payment options and delivery methods, or other questions, please send an email to email@example.com.